Myriad Genetics Tries To Ditch Billing Fraud Stock Drop Suit
Myriad Genetics Inc. and its directors asked a Utah federal judge to throw out a securities fraud class action against them on Tuesday, claiming that investors relied on an "armchair legal...To view the full article, register now.
Already a subscriber? Click here to view full article